Related Experiment Video

Updated: May 11, 2026

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

miR-221 promotes tumorigenesis in human triple negative breast cancer cells

Rounak Nassirpour1, Pramod P Mehta, Sangita M Baxi

  • 1Oncology Research, Pfizer Worldwide Research and Development, San Diego, California, United States of America.

Plos One
|May 3, 2013
PubMed

Insights

MicroRNA-221 (miR-221) drives triple-negative breast cancer (TNBC) growth and spread. Inhibiting miR-221 halts cancer progression and induces cell death, offering a potential therapeutic target for TNBC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Triple-negative breast cancer (TNBC) presents a poor prognosis due to resistance to apoptosis and aggressive cellular behavior.
  • TNBCs lack specific molecular markers and effective targeted therapies.
  • MicroRNAs (miRNAs) like miR-221 are implicated in cancer development and progression.

Purpose of the Study:

  • To investigate the specific role of miR-221 in triple-negative breast cancer (TNBC) pathogenesis.
  • To evaluate the therapeutic potential of targeting miR-221 in TNBC models.

Main Methods:

  • Characterization of miR-221 expression in various breast cancer subtypes.
  • In vitro studies involving miR-221 knockdown to assess effects on cell cycle, apoptosis, proliferation, migration, and invasion in TNBC cell lines.
  • In vivo studies using mouse models to evaluate the impact of miR-221 knockdown on tumor growth.
  • Analysis of downstream targets, including p27(kip1), E-cadherin, Snail, and Slug.

Main Results:

  • miR-221 knockdown inhibited cell cycle progression, induced apoptosis, and reduced proliferation in vitro.
  • Targeting miR-221 suppressed tumor growth in vivo by downregulating p27(kip1).
  • miR-221 inhibition decreased cell migration and invasion by modulating E-cadherin, Snail, and Slug expression in TNBC cells.

Conclusions:

  • miR-221 functions as an oncogene in triple-negative breast cancer.
  • miR-221 is critical for TNBC tumorigenesis, proliferation, and metastasis.
  • Targeting miR-221 represents a promising therapeutic strategy for TNBC.

More Related Videos

The Use of Mouse Mammary Tumor Cells in an In Vitro Invasion Assay as a Measure of Oncogenic Cell Behavior08:12

The Use of Mouse Mammary Tumor Cells in an In Vitro Invasion Assay as a Measure of Oncogenic Cell Behavior

Published on: June 12, 2019

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...